Stay updated on Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Sign up to get notified when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.

Latest updates to the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page
- Check2 days agoChange DetectedNo substantive changes detected in the study record; the title, conditions, eligibility criteria, study design, primary and secondary outcomes, and locations appear unchanged from the prior version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check31 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference3%

- Check38 days agoChange DetectedPage update adds version v3.1.0 and removes several substantive drug-safety topics and a prior version note.SummaryDifference0.5%

- Check53 days agoChange DetectedThe page revision was bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check67 days agoChange DetectedThe web page has updated its facility and location information, now listing 46 locations and providing specific details about various countries and cities involved in the study. Additionally, it has introduced new content related to drug safety and counterfeit drugs.SummaryDifference8%

Stay in the know with updates to Anamorelin HCl in NSCLC-Cachexia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anamorelin HCl in NSCLC-Cachexia Clinical Trial page.